GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced positive results from its phase III clinical trials for a ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...

Adults who are smokers are less likely to be prescribed a GLP-1 than nonsmokers, even though smokers are more likely to be eligible to receive a medication, according to findings published in Diabetes ...